461
Views
37
CrossRef citations to date
0
Altmetric
Critical Care

Understanding the availability, prevalence of use, desired effects, acute toxicity and dependence potential of the novel opioid MT-45

, , &
Pages 54-59 | Received 17 Sep 2014, Accepted 28 Oct 2014, Published online: 28 Nov 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Joanna Hockenhull, David M. Wood & Paul I. Dargan. (2020) The Availability of Modafinil and Methylphenidate Purchased from the Internet in the United Kingdom Without a Prescription. Substance Use & Misuse 55:1, pages 56-65.
Read now
Charles R Caffrey & Patrick M Lank. (2018) When good times go bad: managing ‘legal high’ complications in the emergency department. Open Access Emergency Medicine 10, pages 9-23.
Read now
Nathan C. Stam, Jennifer L. Pilgrim, Olaf H. Drummer, Karen Smith & Dimitri Gerostamoulos. (2018) Catch and release: evaluating the safety of non-fatal heroin overdose management in the out-of-hospital environment. Clinical Toxicology 56:11, pages 1135-1142.
Read now
Aaron Schneir, Imir G. Metushi, Christian Sloane, David J. Benaron & Robert L. Fitzgerald. (2017) Near death from a novel synthetic opioid labeled U-47700: emergence of a new opioid class. Clinical Toxicology 55:1, pages 51-54.
Read now

Articles from other publishers (33)

Deborah Dal Farra, Alice Valdesalici, Giancarlo Zecchinato, Alfio De Sandre, Diego Saccon, Pierluigi Simonato, Ornella Corazza, Giovanni Martinotti, Andrew L. Smith & Marco Solmi. (2022) Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders. International Journal of Environmental Research and Public Health 19:2, pages 915.
Crossref
Abu Shafi, Alex J. Berry, Harry Sumnall, David M. Wood & Derek K. Tracy. (2022) Synthetic opioids: a review and clinical update. Therapeutic Advances in Psychopharmacology 12, pages 204512532211396.
Crossref
Dima Abdulrahim & Owen Bowden-Jones. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances 203 222 .
David Vearrier & Oliver Grundmann. (2021) Clinical Pharmacology, Toxicity, and Abuse Potential of Opioids. The Journal of Clinical Pharmacology 61:S2.
Crossref
Owen Bowden-Jones & Dima Abdulrahim. 2020. Club Drugs and Novel Psychoactive Substances. Club Drugs and Novel Psychoactive Substances.
Liana Fattore, Matteo Marti, Rafaela Mostallino & Maria Paola Castelli. (2020) Sex and Gender Differences in the Effects of Novel Psychoactive Substances. Brain Sciences 10:9, pages 606.
Crossref
Máté Kapitány-Fövény, Ornella Corazza, Shanna Marrinan & Zsolt Demetrovics. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions 307 325 .
. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions 295 425 .
. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions.
S Bilel, NJ Azevedo, R Arfè, M Tirri, A Gregori, G Serpelloni, F De-Giorgio, P Frisoni, M Neri, G Calò & M Marti. (2020) In vitro and in vivo pharmacological characterization of the synthetic opioid MT-45. Neuropharmacology 171, pages 108110.
Crossref
Dino Luethi & Matthias E. Liechti. (2020) Designer drugs: mechanism of action and adverse effects. Archives of Toxicology 94:4, pages 1085-1133.
Crossref
Michael T. Truver & Madeleine J. Swortwood-Gates. (2020) Long-term stability of novel synthetic opioids in blood. Forensic Science International 308, pages 110175.
Crossref
Abu Shafi, Alex J. Berry, Harry Sumnall, David M. Wood & Derek K. Tracy. (2020) New psychoactive substances: a review and updates. Therapeutic Advances in Psychopharmacology 10, pages 204512532096719.
Crossref
Sophie Salle, Sandra Bodeau, Alice Dhersin, Mathilde Ferdonnet, Ruben Goncalves, Marie Lenski, Benjamin Lima, Marie Martin, Jonathan Outreville, Jules Vaucel & Nicolas Fabresse. (2019) Novel synthetic opioids: A review of the literature. Toxicologie Analytique et Clinique 31:4, pages 298-316.
Crossref
Barbara Lovrecic, Mercedes Lovrecic, Branko Gabrovec, Marco Carli, Matteo Pacini, Angelo G. I. Maremmani & Icro Maremmani. (2019) Non-Medical Use of Novel Synthetic Opioids: A New Challenge to Public Health. International Journal of Environmental Research and Public Health 16:2, pages 177.
Crossref
Michael T Truver & Madeleine J Swortwood. (2018) Quantitative Analysis of Novel Synthetic Opioids, Morphine and Buprenorphine in Oral Fluid by LC–MS-MS. Journal of Analytical Toxicology 42:8, pages 554-561.
Crossref
Paolo Frisoni, Erica Bacchio, Sabrine Bilel, Anna Talarico, Rosa Gaudio, Mario Barbieri, Margherita Neri & Matteo Marti. (2018) Novel Synthetic Opioids: The Pathologist’s Point of View. Brain Sciences 8:9, pages 170.
Crossref
Craig McKenzie, Oliver B. Sutcliffe, Kevin D. Read, Paul Scullion, Ola Epemolu, Daniel Fletcher, Anders Helander, Olof Beck, Alexia Rylski, Lysbeth H. Antonides, Jennifer Riley, Shannah A. Smith & Niamh Nic Daeid. (2018) Chemical synthesis, characterisation and in vitro and in vivo metabolism of the synthetic opioid MT-45 and its newly identified fluorinated analogue 2F-MT-45 with metabolite confirmation in urine samples from known drug users. Forensic Toxicology 36:2, pages 359-374.
Crossref
Patil Armenian, Kathy T. Vo, Jill Barr-Walker & Kara L. Lynch. (2018) Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review. Neuropharmacology 134, pages 121-132.
Crossref
Michael H. Baumann, Susruta Majumdar, Valerie Le Rouzic, Amanda Hunkele, Rajendra Uprety, Xi Ping Huang, Jin Xu, Bryan L. Roth, Ying-Xian Pan & Gavril W. Pasternak. (2018) Pharmacological characterization of novel synthetic opioids (NSO) found in the recreational drug marketplace. Neuropharmacology 134, pages 101-107.
Crossref
Patrick M. Beardsley & Yan Zhang. 2018. New Psychoactive Substances. New Psychoactive Substances 353 381 .
Barry K. Logan, Amanda L.A. Mohr, Melissa Friscia, Alex J. Krotulski, Donna M. Papsun, Sherri L. Kacinko, Jeri D. Ropero-Miller & Marilyn A. Huestis. (2017) Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013–2016: A Review. Journal of Analytical Toxicology 41:7, pages 573-610.
Crossref
Helena Fels, Julia Krueger, Hans Sachs, Frank Musshoff, Matthias Graw, Gabriele Roider & Andreas Stoever. (2017) Two fatalities associated with synthetic opioids: AH-7921 and MT-45. Forensic Science International 277, pages e30-e35.
Crossref
Matthew P. Prekupec, Peter A. Mansky & Michael H. Baumann. (2017) Misuse of Novel Synthetic Opioids: A Deadly New Trend. Journal of Addiction Medicine 11:4, pages 256-265.
Crossref
Jolanta B. Zawilska. (2017) An Expanding World of Novel Psychoactive Substances: Opioids. Frontiers in Psychiatry 8.
Crossref
Noreen D Mdege, Nick Meader, Charlie Lloyd, Steve Parrott & Jim McCambridge. (2017) The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations. Public Health Research 5:4, pages 1-138.
Crossref
Marcin Rojkiewicz, Milena Majchrzak, Rafał Celiński, Piotr Kuś & Mieczysław Sajewicz. (2017) Identification and physicochemical characterization of 4-fluorobutyrfentanyl (1-((4-fluorophenyl)(1-phenethylpiperidin-4-yl)amino)butan-1-one, 4-FBF) in seized materials and post-mortem biological samples. Drug Testing and Analysis 9:3, pages 405-414.
Crossref
Richard J. Bodnar. (2017) Endogenous Opiates and Behavior: 2015. Peptides 88, pages 126-188.
Crossref
Hannah R. Fudin, Jennifer L. Babin, Alisyn L. Hansen & Sidhartha D. Ray. 2017. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 31 55 .
Markus R. Meyer. (2016) New psychoactive substances: an overview on recent publications on their toxicodynamics and toxicokinetics. Archives of Toxicology 90:10, pages 2421-2444.
Crossref
Donna Papsun, Alison Krywanczyk, James C. Vose, Elizabeth A. Bundock & Barry K. Logan. (2016) Analysis of MT-45, a Novel Synthetic Opioid, in Human Whole Blood by LC–MS-MS and Its Identification in a Drug-Related Death. Journal of Analytical Toxicology 40:4, pages 313-317.
Crossref
Jolanta B. Zawilska & Dariusz Andrzejczak. (2015) Next generation of novel psychoactive substances on the horizon – A complex problem to face. Drug and Alcohol Dependence 157, pages 1-17.
Crossref
James H. Ho, George P. Bailey, John R. H. Archer, Paul I. Dargan & David M. Wood. (2015) Ethylphenidate: availability, patterns of use, and acute effects of this novel psychoactive substance. European Journal of Clinical Pharmacology 71:10, pages 1185-1196.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.